Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.31 |
| ▸ | CASR | P41180 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4240739 | 0.91 | USP2 (0.44) | HSD17B10TDP1USP2 | |
| SCHEMBL16809992 | 0.85 | HSD17B10 (0.33) | HSD17B10 | |
| SCHEMBL29690346 | 0.85 | HSD17B10 (0.33) | HSD17B10 | |
| SCHEMBL8343333 | 0.85 | HSD17B10 (0.36) | HSD17B10TDP1 | |
| SCHEMBL29690178 | 0.83 | HSD17B10 (0.32) | HSD17B10 | |
| SCHEMBL3278006 | 0.83 | EGFR (0.30) | — | |
| SCHEMBL13286565 | 0.81 | — | — | |
| SCHEMBL13286557 | 0.81 | — | — | |
| SCHEMBL5469118 | 0.81 | — | — | |
| SCHEMBL8343309 | 0.80 | HSD17B10 (0.31) | HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2426099-A1 | Coalescent for aqueous compositions | Rohm and Haas Company (US) | 2012-03-07 | — | — | EP | disclosed |
| US-20120052210-A1 | COALESCENT FOR AQUEOUS COMPOSITIONS | VAN DYK ANTONY KEITH (US) | 2012-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120052210-A1 | COALESCENT FOR AQUEOUS COMPOSITIONS | DGAT2, DGAT1, DAGLB | HSD17B10 143/4885TDP1 2844/4885USP2 968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.